SPONSOR
Moleculin Biotech, Inc.
Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Acute Myeloid Leukaemia (AML)
Moleculin Biotech, Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Acute Myeloid Leukaemia (AML).
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Moleculin Biotech, Inc.
How many clinical trials has Moleculin Biotech, Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Moleculin Biotech, Inc., of which 1 are actively recruiting participants. These trials cover conditions including Acute Myeloid Leukaemia (AML). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Moleculin Biotech, Inc. research focus on?
Moleculin Biotech, Inc. clinical trials span Acute Myeloid Leukaemia (AML). The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Moleculin Biotech, Inc. clinical trial?
To participate in a Moleculin Biotech, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Moleculin Biotech, Inc. trials with current recruitment status updated daily.
Clinical Trials by Moleculin Biotech, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology